Strides Pharma Science Ltd
NSE:STAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Strides Pharma Science Ltd
NSE:STAR
|
IN |
|
Brother Industries Ltd
TSE:6448
|
JP |
|
Bathurst Resources Ltd
ASX:BRL
|
NZ |
|
B
|
BeautySkin Co Ltd
KOSDAQ:406820
|
KR |
|
Woori Financial Group Inc
KRX:316140
|
KR |
|
Kingfisher PLC
F:KFI2
|
UK |
|
Acerinox SA
MAD:ACX
|
ES |
|
P
|
Pacific Metals Co Ltd
F:PYV
|
JP |
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
Bragg Gaming Group Inc
F:SL4
|
CA |
|
E
|
Eidesvik Offshore ASA
XMUN:E1V
|
NO |
|
W
|
WPP PLC
SWB:0WP
|
UK |
|
Figma Inc
F:1S2
|
US |
|
Taoweave Inc
NASDAQ:TWAV
|
US |
|
D
|
Douglas Elliman Inc
F:8OT
|
US |
|
I
|
IntroMedic Co Ltd
KOSDAQ:150840
|
KR |
|
Genco Shipping & Trading Ltd
NYSE:GNK
|
US |
|
A
|
Altimmune Inc
F:3G0
|
US |
|
Sun Peak Metals Corp
XTSX:PEAK
|
CA |
|
Kion Group AG
OTC:KIGRY
|
DE |
|
E
|
Eratex Djaja Tbk PT
IDX:ERTX
|
ID |
|
E
|
Ecograf Ltd
OTC:ECGFF
|
AU |
Bankruptcy Probability
Strides Pharma Science Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Strides Pharma Science Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Strides Pharma Science Ltd
NSE:STAR
|
95.2B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
378.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
347.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
199.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
276.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
169.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Strides Pharma Science Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Strides Pharma Science Ltd has total debt of 6B INR. This includes both short-term (0 INR) and long-term (6B INR) debt.
You can find a full breakdown on its Balance Sheet.